Episode description

Imagine que você precisa correr de um ponto A a um ponto B o mais rápido possível. Qual a velocidade máxima que você conseguiria manter? Agora imagine que você precisa levantar um peso. Um botijão de gás ou um móvel. Qual o peso máximo que você conseguiria levantar? Agora imagine essas mesmas situações onde no ponto B tem uma pessoa que você ama muito que está entre a vida e a morte esperando um remédio que está contigo no ponto A. Será que você não conseguiria um pouquinho mais do seu desempenho físico? Onde estava essa força? De onde saiu aquela resistência física? Quando falamos de efeito placebo no esporte estamos falando de mecanismos que podem dar um boost nas nossas capacidades físicas que destravam algumas reservas fisiológicas.

Patronato do SciCast:

• Patreon SciCast
• Padrim SciCast
• PicPay SciCast

Sua pequena contribuição ajuda o Portal Deviante a continuar divulgando Ciência!

Contatos:

• contato@scicast.com.br
• https://twitter.com/scicastpodcast
• https://www.facebook.com/scicastpodcast
• https://instagram.com/scicastpodcast

Fale conosco! E não esqueça de deixar o seu comentário na postagem desse episódio!

Expediente:

Produção Geral: Tarik Fernandes e Fernando Malta

Equipe de Gravação: Tarik Fernandes, Marcelo de Matos, Yuri Motoyama, Lucas Vieira, Guilherme Ozaki, André Bacchi

Edição: TalknCast

Citação ABNT:Scicast #481: Placebo nos exercícios. Locução: Tarik Fernandes, Marcelo de Matos, Yuri Motoyama, Lucas Vieira, Guilherme Ozaki, André Bacchi. [S.l.] Portal Deviante, 15/04/2022. Podcast. Disponível em: https://www.deviante.com.br/podcasts/scicast-481

placebo with no treatment. N Engl J Med. 2001 May 24;344(21):1594-602. PubMed PMID: 11372012. Epub 2001/05/24. eng.

1. Fanti-Oren S, Birenbaum-Carmeli D, Eliakim A, Pantanowitz M, Nemet D. The effect of placebo on endurance capacity in normal weight children – a randomized trial. BMC Pediatr. 2019 Jan 10;19(1):15. PubMed PMID: 30630461. Pubmed Central PMCID: PMC6327389. Epub 2019/01/12. eng.
2. Hrobjartsson A, Gotzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev. 2010 Jan 20(1):Cd003974. PubMed PMID: 20091554. Epub 2010/01/22. eng.
3. Pecina M, Bohnert AS, Sikora M, Avery ET, Langenecker SA, Mickey BJ, et al. Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression. JAMA Psychiatry. 2015 Nov;72(11):1087-94. PubMed PMID: 26421634. Pubmed Central PMCID: PMC4758856. Epub 2015/10/01. eng.
4. Beedie CJ, Foad AJ. The placebo effect in sports performance: a brief review. Sports Med. 2009;39(4):313-29. PubMed PMID: 19317519. Epub 2009/03/26. eng.
5. Beedie CJ, Stuart EM, Coleman DA, Foad AJ. Placebo effects of caffeine on cycling performance. Med Sci Sports Exerc. 2006 Dec;38(12):2159-64. PubMed PMID: 17146324. Epub 2006/12/06. eng.
6. McClung M, Collins D. “Because I know it will!”: placebo effects of an ergogenic aid on athletic performance. J Sport Exerc Psychol. 2007 Jun;29(3):382-94. PubMed PMID: 17876973. Epub 2007/09/20. eng.
7. St Clair Gibson A, Swart J, Tucker R. The interaction of psychological and physiological homeostatic drives and role of general control principles in the regulation of physiological systems, exercise and the fatigue process – The Integrative Governor theory. Eur J Sport Sci. 2018 Feb;18(1):25-36. PubMed PMID: 28478704. Epub 2017/05/10. eng.
8. Jones HS, Williams EL, Bridge CA, Marchant D, Midgley AW, Micklewright D, et al. Physiological and psychological effects of deception on pacing strategy and performance: a review. Sports Med. 2013 Dec;43(12):1243-57. PubMed PMID: 24002790. Epub 2013/09/05. eng.
9. Haour F. Mechanisms of the placebo effect and of conditioning. Neuroimmunomodulation. 2005;12(4):195-200. PubMed PMID: 15990450. Epub 2005/07/02. eng.
10. Bérdi M, Köteles F, Szabó A, Bárdos G. Placebo effects in sport and exercise: A meta-analysis. European Journal of Mental Health. 2011;6(2):196-212.
11. Hargreaves M. Fatigue mechanisms determining exercise performance: integrative physiology is systems biology. J Appl Physiol. 2008 May;104(5):1541-2. PubMed PMID: 18239081. Epub 2008/02/02. eng.
12. Falcon A. Aristotle on causality. The Stanford Encyclopedia of Philosophy (Spring 2015 Edition). 2006.
13. Hogan JA. A framework for the study of behavior. Behavioural processes. 2015;117:105-13.
14. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet. 2010 Feb 20;375(9715):686-95. PubMed PMID: 20171404. Pubmed Central PMCID: PMC2832199. Epub 2010/02/23. eng.
15. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet. 2010 Feb 20;375(9715):686-95. PubMed PMID: 20171404. Pubmed Central PMCID: PMC2832199. Epub 2010/02/23. eng.
16. Colloca L, Benedetti F. Placebos and painkillers: is mind as real as matter? Nat Rev Neurosci. 2005 Jul;6(7):545-52. PubMed PMID: 15995725. Epub 2005/07/05. eng.
17. Holden JE, Jeong Y, Forrest JM. The endogenous opioid system and clinical pain management. AACN Clin Issues. 2005 Jul-Sep;16(3):291-301. PubMed PMID: 16082232. Epub 2005/08/06. eng.
18. Colloca L, Klinger R, Flor H, Bingel U. Placebo analgesia: psychological and neurobiological mechanisms. Pain. 2013;154(4):511-4. PubMed PMID: 23473783. Epub 02/13.
19. Amann M, Proctor LT, Sebranek JJ, Pegelow DF, Dempsey JA. Opioid-mediated muscle afferents inhibit central motor drive and limit peripheral muscle fatigue development in humans. J Physiol. 2009 Jan 15;587(1):271-83. PubMed PMID: 19015193. Pubmed Central PMCID: PMC2670040. Epub 2008/11/19. eng.
20. Amann M, Blain GM, Proctor LT, Sebranek JJ, Pegelow DF, Dempsey JA. Implications of group III and IV muscle afferents for high-intensity endurance exercise performance in humans. J Physiol. 2011 Nov 1;589(Pt 21):5299-309. PubMed PMID: 21878520. Pubmed Central PMCID: PMC3225681. Epub 2011/09/01. eng.
21. Hilty L, Lutz K, Maurer K, Rodenkirch T, Spengler CM, Boutellier U, et al. Spinal opioid receptor-sensitive muscle afferents contribute to the fatigue-induced increase in intracortical inhibition in healthy humans. Exp Physiol. 2011 May;96(5):505-17. PubMed PMID: 21317218. Epub 2011/02/15. eng.
22. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annual review of medicine. 2009;60:355-66. PubMed PMID: 19630576.
23. Barchas JD, Freedman DX. Brain amines: response to physiological stress. Biochem Pharmacol. 1963 Oct;12:1232-5. PubMed PMID: 14074126. Epub 1963/10/01. eng.
24. Bailey SP, Davis JM, Ahlborn EN. Effect of increased brain serotonergic activity on endurance performance in the rat. Acta Physiol Scand. 1992 May;145(1):75-6. PubMed PMID: 1502916. Epub 1992/05/01. eng.
25. Bailey SP, Davis JM, Ahlborn EN. Serotonergic agonists and antagonists affect endurance performance in the rat. Int J Sports Med. 1993 Aug;14(6):330-3. PubMed PMID: 8407063. Epub 1993/08/01. eng.
26. Wilson WM, Maughan RJ. Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: administration of paroxetine, a 5-HT re-uptake inhibitor, reduces the capacity to perform prolonged exercise. Exp Physiol. 1992 Nov;77(6):921-4. PubMed PMID: 1489548. Epub 1992/11/01. eng.
27. Strachan AT, Leiper JB, Maughan RJ. Paroxetine administration failed [corrected] to influence human exercise capacity, perceived effort or hormone responses during prolonged exercise in a warm environment. Exp Physiol. 2004 Nov;89(6):657-64. PubMed PMID: 15328306. Epub 2004/08/26. eng.
28. Schultz W. Multiple dopamine functions at different time courses. Annu Rev Neurosci. 2007;30:259-88. PubMed PMID: 17600522. Epub 2007/06/30. eng.
29. de la Fuente-Fernandez R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ. Expectation and dopamine release: mechanism of the placebo effect in Parkinson’s disease. Science. 2001 Aug 10;293(5532):1164-6. PubMed PMID: 11498597. Epub 2001/08/11. eng.
30. Davis JM, Bailey SP. Possible mechanisms of central nervous system fatigue during exercise. Med Sci Sports Exerc. 1997 Jan;29(1):45-57. PubMed PMID: 9000155. Epub 1997/01/01. eng.
31. Kaasinen V, Aalto S, Nagren K, Rinne JO. Expectation of caffeine induces dopaminergic responses in humans. Eur J Neurosci. 2004 Apr;19(8):2352-6. PubMed PMID: 15090062. Epub 2004/04/20. eng.
32. DeLong MR, Alexander GE, Georgopoulos AP, Crutcher MD, Mitchell SJ, Richardson RT. Role of basal ganglia in limb movements. Hum Neurobiol. 1984;2(4):235-44. PubMed PMID: 6715208. Epub 1984/01/01. eng.
33. Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, et al. Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci. 2005 Aug 24;25(34):7754-62. PubMed PMID: 16120776. Epub 2005/08/27. eng.

\66. Saunders B, de Oliveira LF, da Silva RP, de Salles Painelli V, Goncalves LS, Yamaguchi G, et al. Placebo in sports nutrition: a proof-of-principle study involving caffeine supplementation. Scand J Med Sci Sports. 2017 Nov;27(11):1240-7. PubMed PMID: 27882605. Epub 2016/11/25. eng.

1. Pollo A, Carlino E, Benedetti F. The top-down influence of ergogenic placebos on muscle work and fatigue. Eur J Neurosci. 2008 Jul;28(2):379-88. PubMed PMID: 18702709. Epub 2008/08/16. eng.
2. Gracely RH, Dubner R, Deeter WR, Wolskee PJ. Clinicians’ expectations influence placebo analgesia. Lancet. 1985 Jan 5;1(8419):43. PubMed PMID: 2856960. Epub 1985/01/05. eng.
3. Goebel MU, Trebst AE, Steiner J, Xie YF, Exton MS, Frede S, et al. Behavioral conditioning of immunosuppression is possible in humans. Faseb j. 2002 Dec;16(14):1869-73. PubMed PMID: 12468450. Epub 2002/12/07. eng.
4. Silberman S. Healing words: The placebo effect and journalism at the mind-body boundary. Placebo talks: Modern perspectives on placebos in society. New York, NY, US: Oxford University Press; 2016. p. 158-69.
5. Ader R, Cohen N. Psychoneuroimmunology: conditioning and stress. Annu Rev Psychol. 1993;44:53-85. PubMed PMID: 8434895. Epub 1993/01/01. eng.
6. Stockhorst U, Mahl N, Krueger M, Huenig A, Schottenfeld-Naor Y, Huebinger A, et al. Classical conditioning and conditionability of insulin and glucose effects in healthy humans. Physiol Behav. 2004 May;81(3):375-88. PubMed PMID: 15135009. Epub 2004/05/12. eng.
7. LARQUIN-CASTILLO M, GONZÁLEZ-PADRÓN Á, RODRÍGUEZ-MARTÍN BC. Intervenciones Placebo Para Incrementar el Rendimiento Deportivo: un Tema Revisitado. Revista Colombiana de Psicología. 2015;24:85-97.
8. Sunshine A, Laska E, Meisner M, Morgan S. Analgesic studies of indomethacin as analyzed by computer techniques. Clin Pharmacol Ther. 1964 Nov-Dec;5:699-707. PubMed PMID: 14226185. Epub 1964/11/01. eng.

See omnystudio.com/listener for privacy information.